IL108810A0 - Optical isomerization inhibitor and pharmaceutical compositions containing the same - Google Patents

Optical isomerization inhibitor and pharmaceutical compositions containing the same

Info

Publication number
IL108810A0
IL108810A0 IL10881094A IL10881094A IL108810A0 IL 108810 A0 IL108810 A0 IL 108810A0 IL 10881094 A IL10881094 A IL 10881094A IL 10881094 A IL10881094 A IL 10881094A IL 108810 A0 IL108810 A0 IL 108810A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
optical isomerization
isomerization inhibitor
Prior art date
Application number
IL10881094A
Other languages
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL108810A0 publication Critical patent/IL108810A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00Purification; Separation; Stabilisation; Use of additives
    • C07B63/04Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10881094A 1993-03-03 1994-03-01 Optical isomerization inhibitor and pharmaceutical compositions containing the same IL108810A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4243093 1993-03-03

Publications (1)

Publication Number Publication Date
IL108810A0 true IL108810A0 (en) 1994-06-24

Family

ID=12635853

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10881094A IL108810A0 (en) 1993-03-03 1994-03-01 Optical isomerization inhibitor and pharmaceutical compositions containing the same

Country Status (10)

Country Link
EP (1) EP0687473A1 (xx)
KR (1) KR960700753A (xx)
CN (1) CN1118575A (xx)
AU (1) AU6045994A (xx)
CA (1) CA2157383A1 (xx)
HU (1) HUT70950A (xx)
IL (1) IL108810A0 (xx)
TW (1) TW264390B (xx)
WO (1) WO1994020143A1 (xx)
ZA (1) ZA941209B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
AUPQ899400A0 (en) * 2000-07-26 2000-08-17 Csl Limited A method of stabilisation and compositions for use therein
EP1714656B8 (en) * 2004-02-06 2017-09-20 Chugai Seiyaku Kabushiki Kaisha Ed-71 preparation
US20070292501A1 (en) * 2006-06-05 2007-12-20 Udell Ronald G Chewable soft gelatin capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56127309A (en) * 1980-03-11 1981-10-06 Dai Ichi Seiyaku Co Ltd Zeolite support for ascorbic acid
JPS5780328A (en) * 1980-11-06 1982-05-19 Sumitomo Chem Co Ltd Preparation of stable pharmaceutical preparation
JPS649285A (en) * 1987-06-30 1989-01-12 Shiseido Co Ltd Antioxidant
FR2630440B1 (fr) * 1988-04-25 1991-09-20 Jouveinal Sa Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique
IL91361A (en) * 1988-09-09 1994-10-07 Fujisawa Pharmaceutical Co Benzodiazepinone compounds [4,1] connected via positions 1 and 9 and carrying two transducers, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CA2157383A1 (en) 1994-09-15
ZA941209B (en) 1994-09-19
WO1994020143A1 (en) 1994-09-15
HU9402538D0 (en) 1994-11-28
AU6045994A (en) 1994-09-26
HUT70950A (en) 1995-11-28
CN1118575A (zh) 1996-03-13
EP0687473A1 (en) 1995-12-20
KR960700753A (ko) 1996-02-24
EP0687473A4 (xx) 1996-01-24
TW264390B (xx) 1995-12-01

Similar Documents

Publication Publication Date Title
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
GB9319568D0 (en) Pharmaceutical compositions and usages
HU9402974D0 (en) Pharmaceutical composition
GB9317686D0 (en) Pharmaceutical compositions
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
ZA946439B (en) Liquid compositions
GB9316580D0 (en) Pharmaceutical composition
GB9317610D0 (en) Pharmaceutical compositions
GB9504040D0 (en) Arylsulfonamide derivative and pharmaceutical composition containing the same
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
PL314036A1 (en) Pharmaceutical composition
IL108810A0 (en) Optical isomerization inhibitor and pharmaceutical compositions containing the same
CA2100836A1 (en) Pharmaceutical composition
GB9317504D0 (en) Pharmaceutical compositions
ZA945752B (en) Pharmaceutical composition
GB9318880D0 (en) Pharmaceutical composition
AU7536794A (en) Liquid compositions
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
HUT73481A (en) Tropane-derivates having analgesic and nootropic effect and pharmaceutical compositions containing the same
AU4706193A (en) Liquid compositions
SG47980A1 (en) Pharmaceutical compositions
GB9318350D0 (en) Pharmaceutical composition
HU9303386D0 (en) Pharmaceutical composition
GB9320688D0 (en) Pharmaceutical composition
HU9303511D0 (en) Pharmaceutical composition